Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy

Journal of Clinical Virology

Volumn 25, Issue SUPPL. 3, 2002, Pages 73-79

  Lackner, Herwig ^a   Moser, Andrea ^a   Benesch, Martin ^a   Deutsch, Johann ^a   Kessler, Harald H ^b   Kerbl, Reinhold ^a   Schwinger, Wolfgang ^a   Dornbusch, Hans Jürgen ^a   Sovinz, Petra ^a   Urban, Christian ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Children; Chronic hepatitis B; Famciclovir; HBV DNA; Interferon; Seroconversion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; FAMCICLOVIR; HEMOGLOBIN; HEPATITIS B(E) ANTIGEN; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON; VIRUS DNA;

ADOLESCENT; ANTIBODY TITER; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; FEMALE; FLU LIKE SYNDROME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 0036900299     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6532(02)00189-0     Document Type: Conference Paper

References (32)

1. Ballauff A., Krähe J., Jansen B., Roß R.S., Roggendorf H., Havers W. Chronic liver disease after treatment of malignant diseases in children. Klin. Pädiatr. 211:1999;49-52.
2. Barbera C., Bortolotti F., Crivellaro C., Coscia A., Zancan L., Cadrobbi P., Nebbia G., Pillan M.N., Lepore L., Parrella T. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology. 20:1994;287-290.
3. Bartholomeusz A., Groenen L.C., Locarnini S.A. Clinical experience with famciclovir against hepatitis B virus. Intervirology. 40:1997;337-342.
4. Bortolotti F., Calzia R., Vegnente A., Cadrobbi P., Rugge M., Armigliato M., Marazzi M.G., Iorio R., Crivellaro C., Piscopo R. Chronic hepatitis in childhood: the spectrum of the disease. Gut. 29:1988;659-664.
5. Bortolotti F., Cadrobbi P., Crivellaro C., Guido M., Rugge M., Noventa F., Calzia R., Realdi G. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology. 99:1990;805-810.
6. Cirelli R., Herne K., McCrary M., Lee P., Tyring S.K. Famciclovir: review of clinical efficacy and safety. Antiviral Res. 29:1996;141-151.
7. Dikici B., Bosnak M., Kara I.H., Dogru O., Dagli A., Gürkan F., Haspolat K. Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection. Pediatr Infect Dis. 20:2001;988-992.
8. Evans A.A., Fine M., London W.T. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J. Infect. Dis. 176:1997;845-850.
9. Giacchino R., Facco F., Giambartolomei G., Navone C., Timitilli A., Cirillo C., Barigione G., Terragna A. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon. Chemioterapia. 7:(Suppl. 3):1988;S20-S25.
10. Gregorio G.V., Jara P., Hierro L., Diaz C., de la Vega A., Vegnente A., Iorio R., Bortolotti F., Crivellaro C., Zancan L., Daniels H., Portmann B., Mieli-Vergani G. Lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology. 23:1996;700-707.
11. Ikeda K., Saitoh S., Suzuki Y., Kobayashi M., Tsubota A., Fukuda M., Koida I., Arase Y., Chayama K., Murashima N., Kumada H. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus. Cancer. 82:1998;827-835.
12. Jara P., Bortolotti F. Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J. Pediatr. Gastroenterol. Nutr. 29:1999;163-170.
13. Kessler H.H., Pierer K., Dragon E., Lackner H., Santner B., Stuenzner D., Stelzl E., Waitzl B., Marth E. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin. Diagn. Virol. 9:1998;37-43.
14. Locasciulli A., Vergani G.M., Uderzo C., Jean G., Cattaneo M., Vergani D., Portmann B., Masera G. Chronic liver disease in children with leukemia in long-term remission. Cancer. 52:1983;1080-1087.
15. 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet. II:1988;298-302.
16. Marques A.R., Lau D.T., McKenzie R., Straus S.E., Hoofnagle J.H. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. J. Infect. Dis. 178:1998;1483-1487.
17. Perrillo R.P., Schiff E.R., Davis G.L., Bodenheimer H.C. Jr., Lindsay K., Payne J., Dienstag J.L., O'Brien C., Tamburro C., Jacobson I.M. A randomized controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N. Engl. J. Med. 323:1990;295-301.
18. Rossetti F., Cesaro S., Pizzocchero P., Cadrobbi P., Guido M., Zanesco L. Chronic hepatitis B surface antigen-negative hepatitis after treatment of malignancy. J. Pediatr. 121:1992;39-43.
19. Ruiz Moreno M. Interferon treatment in children with chronic hepatitis B. J. Hepatol. 22:1995;49-51.
20. Ruiz Moreno M., Jimenez J., Porres J.C., Bartolome J., Moreno A., Carreno V. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B. Digestion. 45:1990;26-33.
21. Sokal E.M., Wirth S., Goyens P., Depreterre A., Cornu C. Interferon alpha-2b therapy in children with chronic hepatitis B. Gut. 34:(Suppl. 2):1993;S87-S90.
22. Sokal E.M., Conjeevaram H.S., Roberts E.A., Alvarez F., Bern E.M., Goyens P., Rosenthal P., Lachaux A., Shelton M., Sarles J., Hoofnagle J. Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology. 114:1998;988-995.
23. Tabor E., Gerety R.J., Mott M., Wilbur J. Prevalence of hepatitis B in a high-risk setting: a serologic study of patients and staff in a pediatric oncology unit. Pediatrics. 61:1978;711-715.
24. Torre D., Tambini R. Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. Clin. Infect. Dis. 23:1996;131-137.
25. Torresi J., Locarnini S. Antiviral chemotherapy for the treatment of hepatitis B virus infections. Gastroenterology. 118:(Suppl. 1):2000;S83-S103.
26. Utili R., Sagnelli E., Galanti B., Aprea L., Cesaro G., Digilio G., Filippini P., Felaco F.M., Gaeta G.B., Marrone A. Prolonged treatment of children with chronic hepatitis B with recombinant alpha2a-interferon: a controlled randomized study. Am. J. Gastroenterol. 86:1991;327-330.
27. Utili R., Sagnelli E., Gaeta G.B., Galanti B., Nardiello S., Felaco F.M., Pasquale G., Marrone A., Aprea L., Pizzella T. Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study. J. Hepatol. 20:1994;163-167.
28. Utili R., Zampino R., Bellopede P., Marracino M., Ragone E., Adinolfi L.E., Ruggiero G., Capasso M., Indolfi P., Casale F., Martini A., Di Tullio M.T. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long term follow-up and effect of interferon treatment. Blood. 94:1999;4046-4052.
29. Wands J.R., Walker J.A., Davis T.T., Waterbury L.A., Owens A.H., Carpenter C.C.J. Hepatitis B in an oncology unit. N. Engl. J. Med. 291:1974;1371-1375.
30. Wirth S. Chronic hepatitis B, D, and C in childhood. Verdauungskrankheiten. 14:1996;22-27.
31. Wirth S., Sokal E., Schaefer E., Pohlenz J., Keller K.M. Die chronische hepatitis B. Monatsschr. Kinderheilkd. 140:1992;775-779.
32. Wu T.C., Tong M.J., Hwang B., Lee S.D., Hu M.M. Primary hepatocellular carcinoma and hepatitis B infection during childhood. Hepatology. 7:1987;46-48.